- Accueil >
- Publications >
- Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancer
Safety and efficacy of 2-weekly cabazitaxel in metastatic castration-resistant prostate cancer
Auteurs
Alice Clément-Zhao, Marie Auvray, Hail Aboudagga, Félix Blanc-Durand, Antoine Angelergues, Yann Alexandre Vano, Florence Mercier, Nader El Awadly, Benjamin Verret, Constance Thibault, Stéphane Oudard